Winton Group LTD Abbott Laboratories Transaction History

Winton Group LTD

$1.31 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$100.73 - $112.44 $4.73 Million - $5.28 Million	46,935 Added 537.69%	55,664 $5.78 Million
Q1 2024 May 14, 2024	BUY	$109.52 - $120.96 $956,000 - $1.06 Million	8,729 New	8,729 $992,000
Q3 2023 Nov 13, 2023	SELL	$95.53 - $114.62 $1.03 Million - $1.23 Million	-10,747 Reduced 18.07%	48,740 $4.72 Million
Q2 2023 Aug 14, 2023	BUY	$100.78 - $112.29 $6 Million - $6.68 Million	59,487 New	59,487 $6.49 Million
Q2 2022 Aug 10, 2022	SELL	$102.07 - $123.37 $379,496 - $458,689	-3,718 Reduced 15.51%	20,249 $2.2 Million
Q1 2022 May 11, 2022	SELL	$114.02 - $139.04 $933,367 - $1.14 Million	-8,186 Reduced 25.46%	23,967 $2.84 Million
Q4 2021 Feb 10, 2022	BUY	$115.53 - $141.46 $2.15 Million - $2.63 Million	18,608 Added 137.38%	32,153 $4.53 Million
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $205,438 - $227,274	1,761 Added 14.94%	13,545 $1.6 Million
Q2 2021 Aug 10, 2021	BUY	$105.79 - $124.53 $744,761 - $876,691	7,040 Added 148.4%	11,784 $1.37 Million
Q1 2021 Jul 21, 2021	BUY	$108.84 - $128.23 $516,336 - $608,323	4,744 New	4,744 $569,000
Q1 2020 May 11, 2020	SELL	$62.82 - $91.86 $296,824 - $434,038	-4,725 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$78.51 - $87.4 $931,285 - $1.04 Million	-11,862 Reduced 71.51%	4,725 $410,000
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $831,412 - $901,509	-10,159 Reduced 37.98%	16,587 $1.39 Million
Q2 2019 Jul 08, 2019	BUY	$72.88 - $85.0 $762,106 - $888,845	10,457 Added 64.2%	26,746 $2.25 Million
Q1 2019 May 13, 2019	BUY	$66.22 - $80.06 $17,084 - $20,655	258 Added 1.61%	16,289 $1.3 Million
Q4 2018 Feb 05, 2019	BUY	$65.56 - $74.27 $425,549 - $482,086	6,491 Added 68.04%	16,031 $1.16 Million
Q3 2018 Nov 02, 2018	BUY	$60.81 - $73.36 $214,051 - $258,227	3,520 Added 58.47%	9,540 $0
Q2 2018 Aug 20, 2018	SELL	$57.57 - $63.54 $143,637 - $158,532	-2,495 Reduced 29.3%	6,020 $0
Q1 2018 May 21, 2018	BUY	$56.27 - $63.62 $6,752 - $7,634	120 Added 1.43%	8,515 $0
Q4 2017 Feb 13, 2018	BUY	$53.68 - $57.47 $241,613 - $258,672	4,501 Added 115.59%	8,395 $479,000
Q3 2017 Nov 13, 2017	SELL	$48.06 - $53.64 $176,284 - $196,751	-3,668 Reduced 48.51%	3,894 $208,000
Q2 2017 Aug 17, 2017	BUY	N/A	7,562	7,562 $368,000

Others Institutions Holding ABT

# of Institutions

3,247

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.02M

Vanguard Group Inc Valley Forge, PA

168M
Shares

$21.7 Billion
0.35% of portfolio
Black Rock Inc. New York, NY

131M
Shares

$16.9 Billion
0.31% of portfolio
State Street Corp Boston, MA

76.7M
Shares

$9.9 Billion
0.36% of portfolio
Capital International Investors Los Angeles, CA

65.7M
Shares

$8.49 Billion
1.49% of portfolio
Capital Research Global Investors Los Angeles, CA

53.3M
Shares

$6.88 Billion
1.31% of portfolio

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Winton Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Winton Group LTD with notifications on news.

Account